Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Daniel Ira Rosenthal, M.D.


This page shows the publications co-authored by Daniel Rosenthal and Thomas Delaney.
Connection Strength

  1. Frequency and Risk Factors for Additional Lesions in the Axial Spine in Subjects With Chordoma: Indications for Screening. Spine (Phila Pa 1976). 2017 Jan 01; 42(1):E37-E40.
    View in: PubMed
    Score: 0.168
  2. Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):254-262.
    View in: PubMed
    Score: 0.165
  3. Differences in sex distribution, anatomic location and MR imaging appearance of pediatric compared to adult chordomas. BMC Med Imaging. 2016 09 08; 16(1):53.
    View in: PubMed
    Score: 0.164
  4. MRI surveillance following treatment of extremity soft tissue sarcoma. J Surg Oncol. 2014 May; 109(6):593-6.
    View in: PubMed
    Score: 0.136
  5. Management of acral myxoinflammatory fibroblastic sarcoma. Cancer. 2010 Dec 15; 116(24):5733-9.
    View in: PubMed
    Score: 0.108
  6. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003 Jul 15; 56(4):1117-27.
    View in: PubMed
    Score: 0.066
  7. Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65(5):1514-21.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.